1. Home
  2. ADMA vs ACIW Comparison

ADMA vs ACIW Comparison

Compare ADMA & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • ACIW
  • Stock Information
  • Founded
  • ADMA 2004
  • ACIW 1975
  • Country
  • ADMA United States
  • ACIW United States
  • Employees
  • ADMA N/A
  • ACIW N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • ACIW EDP Services
  • Sector
  • ADMA Health Care
  • ACIW Technology
  • Exchange
  • ADMA Nasdaq
  • ACIW Nasdaq
  • Market Cap
  • ADMA 5.1B
  • ACIW 4.7B
  • IPO Year
  • ADMA N/A
  • ACIW 1995
  • Fundamental
  • Price
  • ADMA $15.69
  • ACIW $49.38
  • Analyst Decision
  • ADMA Strong Buy
  • ACIW Strong Buy
  • Analyst Count
  • ADMA 3
  • ACIW 3
  • Target Price
  • ADMA $27.67
  • ACIW $60.00
  • AVG Volume (30 Days)
  • ADMA 2.9M
  • ACIW 856.7K
  • Earning Date
  • ADMA 11-06-2025
  • ACIW 11-06-2025
  • Dividend Yield
  • ADMA N/A
  • ACIW N/A
  • EPS Growth
  • ADMA 469.09
  • ACIW 38.68
  • EPS
  • ADMA 0.85
  • ACIW 2.37
  • Revenue
  • ADMA $474,174,000.00
  • ACIW $1,700,613,000.00
  • Revenue This Year
  • ADMA $21.08
  • ACIW $10.58
  • Revenue Next Year
  • ADMA $25.98
  • ACIW $6.98
  • P/E Ratio
  • ADMA $18.53
  • ACIW $20.76
  • Revenue Growth
  • ADMA 43.58
  • ACIW 11.22
  • 52 Week Low
  • ADMA $13.50
  • ACIW $40.45
  • 52 Week High
  • ADMA $25.67
  • ACIW $59.71
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 36.86
  • ACIW 55.57
  • Support Level
  • ADMA $15.14
  • ACIW $49.43
  • Resistance Level
  • ADMA $17.17
  • ACIW $50.94
  • Average True Range (ATR)
  • ADMA 0.55
  • ACIW 1.05
  • MACD
  • ADMA -0.12
  • ACIW -0.14
  • Stochastic Oscillator
  • ADMA 22.59
  • ACIW 40.99

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

Share on Social Networks: